• 10 January 2007
  • News
  • By

BioSuppliers News

Labindia to distribute Ambion products

Labindia to distribute Ambion products

Starting from January 2007, Labindia Instruments, the exclusive distributor of Applied Biosystems in India, will also be distributing Ambion products as a result of the acquisition and integration of Ambion into Applied Biosystems (ABI), an Appelera Corporation Business.

Applied Biosystems had acquired Ambion Inc in March 2006. Both the companies have been the market leaders in their respective fields. The business of Applied Biosystems is focused on the following markets: basic research, commercial research (pharmaceutical and biotechnology) and standardized testing, including forensic human identification, paternity testing and food testing. The company has an installed base of approximately 1,80,000 instrument systems in nearly 100 countries. Ambion has been a market leader in the development and supply of innovative RNA-based life science research and molecular biology products. The company specialized in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting and measuring RNA.

The combination of the comprehensive product portfolio of Applied Biosystems and the broad range of RNA products from Ambion offers the researchers a more complete solution to their application workflow from a single source.

Within the country, Labindia has been associated with Applied Biosystems since 1995. Its main focus has been to provide prompt and efficient service and application support to the users who are involved in the field of life sciences. It has a state-of-the-art application and training center at Gurgaon to provide after-sales support and training to users and potential buyers. In 2005, this facility also started providing microarray service to the biotech industry, which is one of the global advanced gene expression service providers of Applied Biosystems.

 

Agilent launches LSCA Centers of Excellence in India, California and Europe

Agilent Technologies has launched a new product demonstration center in Bangalore, and at its Santa Clara, California, corporate headquarters, showcasing its life sciences and chemical analysis capabilities.

Agilent had recently set up its product demonstration centers in Paris, France; Manchester, the UK and Waldbronn, Germany. Planned for late 2007 is yet another center in Little Falls, Delaware. It also has Centers of Excellence specializing in life sciences and chemical analysis in Beijing, Shanghai and Hajiochi, Japan.

"These centers provide a one-stop customer experience highlighting our entire portfolio of products and services," said Agilent's Chris van Ingen, president, life sciences and chemical analysis. "They demonstrate Agilent's commitment to our customers and business partners as the premier measurement company. We look forward to working alongside our customers on the applications, proof of performance and product demonstrations that these Centers of Excellence will facilitate."

Customers visiting the demonstration centers have the opportunity to interact with Agilent senior management and applications specialists. They are able to observe and participate in proof of performance for Agilent's chemical and bioanalytical systems using their own samples in a state-of-the-art, fully equipped facility.

The 5,000-sft Santa Clara facility houses a complete array of Agilent's core platform products, including liquid and gas chromatography systems, LC and GC mass spectrometry systems and Agilent's DNA Microarray Scanner, the centerpiece of the Agilent microarray platform. The facility features multimedia-equipped conference rooms, a general wet lab, a proteomics prep lab, a genomics lab and an ICP-MS lab.

 

Pall launches coalescer tech to improve process economics

Pall Corporation has launched its PhaseSep and AquaSep liquid/liquid coalescers in India to improve process economics for small-molecule drug manufacturing. Coalescing technology for liquid separation significantly speeds excess water removal from solvent-based feedstreams, improving efficiency and reducing energy consumption. Depending on the application, coalescers can shorten a manufacturing run by many hours, enabling a production facility to significantly increase output.

Organic solvents are commonly used for dissolving, reacting, recovering and purifying the ingredients that make up APIs. However, the presence of small quantities of water can dramatically reduce product yield and significantly increase the cost of solvent recovery. Pall's liquid/liquid coalescers enable a faster and more efficient separation of water from immiscible solvents and can also be used to remove these solvents from wastewater streams, reducing the cost of waste treatment, an official release said.

"Pall's depth of experience in coalescence from different industries enables us to transfer this critical technology to the pharmaceutical market, relieving manufacturers of significant costs associated with energy use and low yields. This technology goes a long way to increasing manufacturing capacity of APIs, which is a critical factor for market growth in China, India and elsewhere in Asia," said Gareth Leach, global API market manager for Pall Life Sciences.

 

Syngene introduces integrated proteomics products

Syngene, a manufacturer of image analysis solutions has introduced a new range of integrated proteomics products for scientists who want rapid, accurate results when producing, imaging and analysing 2D gels. For generating precisely focused 2D protein gels, Syngene supplies the new IEF-SYS, a one tank system designed to save time by allowing users to run 2D gels with both immobilised pH gradient strips and pre-cast acrylamide gels.

Scientists can then generate accurate images of their 2D gels using either Syngene's ProteomeScan scanner or Dyversity, Syngene's powerful CCD based imager. ProteomeScan features the ability to switch between transmittance and reflectance modes to rapidly produce images of up to 12,800 x 12,800-dpi resolution. Dyversity comes complete with a high quality 16-bit CCD camera in a computer-controlled darkroom and can be fitted with filters for imaging all commercially available dyes including Cy dyes. The system guarantees imaging results that are comparable in accuracy to most laser based scanners.

For the next stage in the proteomics workflow, users can automatically transfer the results generated by ProteomeScan and Dyversity into Dymension, Syngene's revolutionary 2D image analysis software. Dymension, the fastest 2D analysis package currently on the market can perform background correction, spot matching and reporting in just minutes, saving users valuable research time.

 

Praj signs contract with Belgium firm

Pune-based Praj Industries, a knowledge based company with expertise and experience in bioprocesses and engineering, has entered into a contract with Biowanze SA, a subsidiary of CropEnergies AG (a Sudzucker Group Company) for license, basic engineering and other services for their proposed 2,40,000 tons per annum Bio-ethanol Complex at Wanze in Belgium. Praj's licence and engineering scope includes the core bio-ethanol process plant comprising liquefaction, fermentation, multi-pressure distillation, dehydration and vinasse evaporation. Wheat and beet syrup will be used as feedstock at this facility. CropEnergies AG is also one of the leading producers of bio-ethanol in Europe. € 5.4 billion Sudzucker Group, with 44 sugar factories spread across Europe, is the largest sugar producer in Europe.

 

BioLife and Corning announce increased cell performance

BioLife Solutions and Corning Incorporated have announced the publication of a report that describes the benefits of the combination of the BioLife CryoStor CS5 with Corning's CellBIND Surface.

The integration of these complementary technologies resulted in a significant increase in the survival and attachment of LNCaP cells as compared to traditional solutions and tissue culture treated (TCT) surfaces. The CryoStor/Corning CellBIND Surface combined approach offers a distinct advantage to the pharmaceutical, drug discovery, and toxicity testing industries by enabling researchers to reduce time and effort presently required to collect, store, retrieve and utilize high-quality cryopreserved cells. This thereby increases productivity and cost-effectiveness of in vitro screening processes.

The data from independent experiments showed that the Cryostor solution and Corning CellBIND surface product combination offered a 58-percent increase in post-preservation cell survival when compared to traditional tissue culture surface and serum and protein based freezing media.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X